| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.052 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |